Duplicate price scheme proposed for exportable medicines

Published: 2013-08-14 06:56:00

Updated: 2013-08-14 06:56:00

The local research organization has recommended a “duplicate price” scheme in which the manufacturer of exportable drugs would refund to the National Health Insurance Corporation the price difference existing between the export price of a locally developed drug and its actual price covered by the national health insurance.

The duplicate price scheme, proposed by the Korea Drug Research Assoc...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.